NIH-HESI Workshop: Assessing Emerging Cell and Gene Therapies for Disease-Specific Therapeutic Applications
October 30, 2026
ARMI Chief Regulatory Officer Dr. Richard McFarland will moderate a panel at the NIH-HESI workshop, December 2–3, 2026. This hybrid event explores in vivo tracking, biodistribution, regulatory considerations, and emerging technologies for cell and gene therapies.
